Page last updated: 2024-11-12

ugonin k

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ugonin K: an antioxidant; isolated from the rhizomes of Helminthostachys zeylanica [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Helminthostachysgenus[no description available]Ophioglossaceae[no description available]
Helminthostachys zeylanicaspecies[no description available]Ophioglossaceae[no description available]

Cross-References

ID SourceID
PubMed CID12114698
CHEMBL ID563689
MeSH IDM0536061

Synonyms (3)

Synonym
CHEMBL563689
ugonin k
2-(3,4-dihydroxyphenyl)-6-[[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]methyl]-5-hydroxy-7-methoxychromen-4-one

Research Excerpts

Overview

Ugonin K is a flavonoid isolated from the roots of Helminthostachys zeylanica, a folk medicine used to strengthen bone mass and cure bone fracture.

ExcerptReferenceRelevance
"Ugonin K is a flavonoid isolated from the roots of Helminthostachys zeylanica, a folk medicine used to strengthen bone mass and cure bone fracture. "( Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Chiou, WF; Huang, YL; Lee, CH; Liao, JF, 2011
)
3.25

Treatment

ExcerptReferenceRelevance
"Pretreatment with ugonin K attenuated H(2)O(2)-induced cell death in a dose-dependent manner."( Neuroprotective effects of ugonin K on hydrogen peroxide-induced cell death in human neuroblastoma SH-SY5Y cells.
Chen, SC; Gean, PW; Huang, LJ; Huang, YC; Kuo, SC; Liaw, CC; Lin, YC, 2009
)
0.97
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID426990Cytotoxicity against human MCF7 cells by MTT assay2009Journal of natural products, Jul, Volume: 72, Issue:7
Anti-inflammatory flavonoids from the rhizomes of Helminthostachys zeylanica.
AID426991Cytotoxicity against human neutrophils assessed as inhibition of LDH releses at 10 uM2009Journal of natural products, Jul, Volume: 72, Issue:7
Anti-inflammatory flavonoids from the rhizomes of Helminthostachys zeylanica.
AID426989Cytotoxicity against human HepG2 cells by MTT assay2009Journal of natural products, Jul, Volume: 72, Issue:7
Anti-inflammatory flavonoids from the rhizomes of Helminthostachys zeylanica.
AID426988Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/Cytochalasin B-induced elastase release2009Journal of natural products, Jul, Volume: 72, Issue:7
Anti-inflammatory flavonoids from the rhizomes of Helminthostachys zeylanica.
AID426987Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/cytochalasin B-induced superoxide radical anion generation2009Journal of natural products, Jul, Volume: 72, Issue:7
Anti-inflammatory flavonoids from the rhizomes of Helminthostachys zeylanica.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.79 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]